Proteins were detected using horseradish peroxidase (HRP)-conjugated IgG secondary antibody (#7074, Cell Signaling and 62-6520, Thermo Fisher Scientific) and SignalFire ECL Reagent (Cell Signaling)
GLP-1 medications can suppress appetite and worsen gastrointestinal symptoms, increasing the risk of malnutrition or sarcopenia issues already prevalent in older CKD patients
it triggers glucose-dependent insulin release from the pancreas (meaning insulin goes up when blood sugar is high, not when it is already normal)
Pham Edwards Life Sciences: US
Most patients experience some side effects, but the difference between a manageable adjustment period and a miserable one is rarely about the drug itself
Potential of New Weight Loss Drugs to Improve Sleep Disorders Associated with Obesity. Retrieved November 30, 2025 Nature Reviews Endocrinology